comparemela.com

Latest Breaking News On - James rothman phd - Page 1 : comparemela.com

Epic Sciences Raises 42M in First Close of Series F Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesRoche bioscienceLloyd sandersEpic sciences incEpic sciencesCorning incGe healthcareArsenal capital partnersBlue ox healthcare partnersDeerfield managementJames rothman phdHealthcare advisory boardNobel laureateChief scientistRichard eglen phd

EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

/PRNewswire/ Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F.

Roche bioscienceLloyd sandersEpic sciences incEpic or sciencesPrnewswire epic sciences incEpic sciencesCorning incGe healthcareEpic scienceCapital partnersBlue ox healthcare partnersDeerfield managementJames rothman phdHealthcare advisory boardNobel laureateChief scientist

EPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

/PRNewswire/ Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F.

Roche bioscienceLloyd sandersEpic sciences incEpic or sciencesPrnewswire epic sciences incEpic sciencesCorning incGe healthcareEpic scienceCapital partnersBlue ox healthcare partnersDeerfield managementJames rothman phdHealthcare advisory boardNobel laureateChief scientist

vimarsana © 2020. All Rights Reserved.